Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.
Press releases published on August 27, 2025
Advent Technologies engages Fata Advisory to Support Business Development for Aerospace, Defense, and Commercial Markets
GlobeNewswire
·
August 27, 2025
LIVERMORE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in fuel cells and hydrogen technologies, is pleased to announce that it has engaged Fata Advisory, LLC to support the Company …
Alpha Tau to Participate in Five September Investor Conferences
GlobeNewswire
·
August 27, 2025
JERUSALEM, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present and meet …
Disc Medicine to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
Kailera Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity, today announced …
Acronis and Intel Partner to Deliver Efficient, AI-Driven Threat Detection for Endpoint Devices
GlobeNewswire
·
August 27, 2025
SCHAFFHAUSEN, Switzerland, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, and Intel, today announced Acronis Cyber Protect Cloud’s availability with AI PCs powered by Intel Core Ultra processors, a new …
Telitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for IgA Nephropathy
GlobeNewswire
·
August 27, 2025
Results reinforce telitacicept’s potential across multiple autoimmune diseases Data anticipated to be presented at an upcoming medical conference CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology …
Flare Therapeutics to Participate in Upcoming Investor Conferences in September
GlobeNewswire
·
August 27, 2025
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that the …
Dyne Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management …
Minovia Therapeutics מודיעה על מענק של 350,000 דולר מקרןCountdown for a Cure לפיתוח סמנים ביולוגיים מבוססי דם של מיטוכונדריה
GlobeNewswire
·
August 27, 2025
חיפה, ישראל, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd("מינוביה" או "החברה"), חברת ביוטכנולוגיה בשלבים קליניים המפתחת טיפולים חדשניים לטיפול במחלות מיטוכונדריאליות ולמאבק בהידרדרות הקשורה לגיל, מודיעה כי נבחרה לקבל מענק של 350,000 דולר מ- …
Invivyd to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that it will present at the following investor conferences: Cantor Global Healthcare Conference 2025 Fireside Chat Date: Wednesday, September 3, 2025 Fireside …
Sionna Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that …
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that management will participate in webcast fireside chats at the following investor conferences: Wells Fargo Healthcare Conference Date/Time: …
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- August 27, 2025 -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, …
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
August 27, 2025
WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the …
TREOS Bio Partners with Charité Berlin and Junshi Biosciences to Launch Pivotal Phase II Clinical Trial in Refractory MSS Colorectal Cancer
GlobeNewswire
·
August 27, 2025
LONDON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- TREOS Bio Ltd., a clinical-stage biotechnology company developing next-generation off-the-shelf peptide cancer immunotherapies, today announced the execution of clinical collaboration agreements with Charité – …
Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 27, 2025
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will attend the upcoming H.C. Wainwright Global Investment Conference in New York City and …
Ocular Therapeutix™ to Participate in September Investor and Scientific Conferences
GlobeNewswire
·
August 27, 2025
BEDFORD, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and …
Destination XL Group, Inc. Reports Second Quarter Financial Results
GlobeNewswire
·
August 27, 2025
Sales of $115.5 million, Breakeven Net Loss per diluted share Extends Credit Facility to August 2030 CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated-commerce specialty retailer of Big + …